Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 156 of 1,261
  1. US 11826325

    Use of Belinostat or pharmaceutically acceptable salt thereof in preparation of drug for treating infection

    The First Affiliated Hospital of Xi'an Jiaotong University · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  2. US 11826315

    STAT3 inhibitors

    Tvardi Therapeutics, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  3. US 11827883

    Dosages and methods for delivering lipid formulated nucleic acid molecules

    Alnylam Pharmaceuticals, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  4. US 11820833

    Peptides that inhibit binding of EPCR to its ligand to treat inflammation

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  5. US 11820870

    Photocontrolled dynamic covalent linkers for polymer networks

    Northwestern University · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  6. US 11820775

    Pyrrolopyrimidine ITK inhibitors

    Aclaris Therapeutics, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  7. US 11819276

    Hyperspectral imaging for early detection of Alzheimer's disease

    Regents of the University of Minnesota · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  8. US 11819554

    Compositions and methods for modulating FMR1 expression

    Fulcrum Therapeutics, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  9. US 11820749

    Centrally active and orally bioavailable uncharged bisoxime antidotes for organophosphate poisoning and methods for making and using them

    The Regents of the University of California · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  10. US 11819496

    Topical roflumilast formulation having improved delivery and plasma half-life

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  11. US 11820781

    Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway

    NURIX THERAPEUTICS, INC. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  12. US 11821003

    Cardiogenic mesoderm formation regulators

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  13. US 11821008

    Liver targeting adeno-associated viral vectors

    BIOMARIN PHARMACEUTICAL INC. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  14. US 11820982

    Treatment of ophthalmic conditions with son of Sevenless 2 (SOS2) inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  15. US 11820773

    Tricyclic compounds

    Aligos Therapeutics, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  16. US 11820826

    Anti-NPR1 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  17. US 11820824

    Antibodies to TIGIT

    Arcus Biosciences, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  18. US 11820815

    Human antibodies to human delta like ligand 4

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  19. US 11819575

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  20. US 11819574

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  21. US 11819573

    Treatment of hip pain with sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  22. US 11819572

    Treatment of pain by administration of sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  23. US 11819571

    Micelle constructs comprising curcumin

    IMMIX BIOPHARMA, INC. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  24. US 11819509

    Lipid compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.